The increasing number of older adults with blood-related disorders and the introduction of reduced intensity conditioning regimens has led to increases in hematopoietic stem cell (HSC) transplantation among older adults and a corresponding increase in the age of siblings who donate HSCs to these patients. Data regarding the donation-related experiences of older donors is lacking. The Related Donor Safety Study (RDSafe) aimed to examine/compare health-related quality of life (HRQoL) of older versus younger HSC donors. 60 peripheral blood stem cell (PBSC) donors ages 18–60 and 104 PBSC donors age >60 completed validated questionnaires at pre-donation, 4 weeks and 1 year post-donation. Prior to donation, older donors had poorer general physica...
There is a lack of evidence about how health-related quality of life (HRQoL), including psychosocial...
Unlike unrelated donor registries, transplant centers lack uniform approaches to related donor asses...
AbstractWe reviewed and analyzed safety and efficacy data after mobilization with granulocyte colony...
The development of reduced-intensity approaches for allogeneic hematopoietic cell transplantation ha...
AbstractAs older patients are eligible for allogeneic hematopoietic cell transplantation (HCT), olde...
AbstractHematopoietic stem cells can be procured from unrelated donors via either the bone marrow (B...
Through the recruitment of immunologic mechanisms, allogeneic hematopoeitic cell transplantation (HC...
Introduction: Allogeneic stem cell transplantation (Allo-SCT) is a well-established treatment option...
The physical reactions to hematopoietic stem cell donation have been extensively studied, but less i...
Here we describe a retrospective analysis of outcomes in 299 patients who underwent peripheral blood...
Live donation benefits recipients, but the long‐term consequences for donors remain uncertain. Renal...
AbstractThe physical reactions to hematopoietic stem cell donation have been extensively studied, bu...
Background: Some countries impose an upper age limit on whole blood (WB) and double red blood cell (...
AbstractThe number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each y...
Data on long-term follow-up of donors for hematopoietic stem cell transplantation (HSCT) are limited...
There is a lack of evidence about how health-related quality of life (HRQoL), including psychosocial...
Unlike unrelated donor registries, transplant centers lack uniform approaches to related donor asses...
AbstractWe reviewed and analyzed safety and efficacy data after mobilization with granulocyte colony...
The development of reduced-intensity approaches for allogeneic hematopoietic cell transplantation ha...
AbstractAs older patients are eligible for allogeneic hematopoietic cell transplantation (HCT), olde...
AbstractHematopoietic stem cells can be procured from unrelated donors via either the bone marrow (B...
Through the recruitment of immunologic mechanisms, allogeneic hematopoeitic cell transplantation (HC...
Introduction: Allogeneic stem cell transplantation (Allo-SCT) is a well-established treatment option...
The physical reactions to hematopoietic stem cell donation have been extensively studied, but less i...
Here we describe a retrospective analysis of outcomes in 299 patients who underwent peripheral blood...
Live donation benefits recipients, but the long‐term consequences for donors remain uncertain. Renal...
AbstractThe physical reactions to hematopoietic stem cell donation have been extensively studied, bu...
Background: Some countries impose an upper age limit on whole blood (WB) and double red blood cell (...
AbstractThe number of allogeneic hematopoietic stem cell (HSC) transplants performed globally each y...
Data on long-term follow-up of donors for hematopoietic stem cell transplantation (HSCT) are limited...
There is a lack of evidence about how health-related quality of life (HRQoL), including psychosocial...
Unlike unrelated donor registries, transplant centers lack uniform approaches to related donor asses...
AbstractWe reviewed and analyzed safety and efficacy data after mobilization with granulocyte colony...